Post Sign in Join
Daily desk

News

Artificial intelligence, technology, science, health and education — reported daily, with the original source attached to every item.

Showing articles about neurology

2 stories

A gauge compares solengepras 150 mg's 1.56-hour OFF-time reduction against placebo's 0.95 hours, highlighting the 37-minute placebo-adjusted benefit from the 341-patient ARISE trial.
🩺 Health Report

Solengepras 150 mg Cuts Parkinson's OFF Time by 37 Minutes vs Placebo in Phase 3 Trial

Cerevance's GPR6 inhibitor solengepras (150 mg) met its primary endpoint in the 341-patient ARISE trial, cutting daily OFF time by 0.61 hou…

EduFabTech · 2h ago · 4 min read
A single IV infusion generates CAR T cells inside the body that clear CD19-positive B cells, in a 16-patient trial spanning four autoimmune diseases with mostly mild side effects.
🩺 Health Study

Single-Infusion In Vivo CAR T-Cell Therapy Eases Four Neurologic Autoimmune Diseases in Small NEJM Trial

A 16-patient trial published in NEJM on September 3, 2026 tested a single-infusion lentiviral vector that generates CD19 CAR T cells inside…

EduFabTech · 25 Sep 2026 · 4 min read